p-321
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2014 (NCT02242032)
Timeline
Indications
Studied for
Mechanism of action
SCNN1A inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- p-321
- p-321
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02824913 | Phase 2 | Jul 1, 2016 | Parion Sciences |
| NCT02831387 | Phase 2 | Jul 1, 2016 | Parion Sciences |
| NCT02242032 | Phase 1 | Jul 1, 2014 | Parion Sciences, Sall Research Medical Center |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Parion Sciences | For profit | 3 | 3 | 2 | 2014 |
| Sall Research Medical Center | Academic/Hospital | 1 | 0 | 1 | 2014 |
2 organizations
Page 1 / 1